Chemical Name: N, N-dimethyl-5-(1H-1, 2, 4-triazol-1-ylmethyl)-1H-indole-3-ethanamine
Rizatriptan benzoate tablets are contraindicated in patients with: Ischemic coronary
3% ≈ 7
Rizatriptan is in a class of medications called selective serotonin receptor agonists
Each compressed tablet contains the following inactive ingredients: Lactose Monohydrate USP NF, Microcrystalline Cellulose USP NF
The other ingredients of Rizatriptan tablets are mannitol (E421), microcrystalline cellulose (E460a)
53 mg of the benzoate salt, respectively)
53 mg of the benzoate salt, respectively)
Rizatriptan benzoate tablets are available for oral administration in strengths of 5 mg and 10 mg (corresponding to 7
265 mg or 14
Rizatriptan benzoate tablets, USP are available in strengths of 5 mg and 10 mg containing 7
Hypersensitivity to active substance or any product ingredients (angioedema and anaphylaxis seen) Rizatriptan Benzoate 10 mg (base) (267) View all images
For non-prescription products, read the label or package ingredients carefully
10 mg Each white-to-off-white, round tablet with "R101" on one side and "rph" on the other side, with no break-line contains 10 mg of rizatriptan (as rizatriptan benzoate)
Each compressed tablet contains the following inactive ingredients: ferric oxide (red), lactose monohydrate, magnesium stearate, maize
Rizatriptan benzoate orally disintegrating tablets should only be used where a clear diagnosis of migraine has been established
Nonmedicinal ingredients: aspartame, calcium silicate, crospovidone, silicified microcrystalline cellulose, sweet orange flavour, magnesium stearate, mannitol
1